Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$218.83 USD
+4.86 (2.27%)
Updated Jul 1, 2022 04:00 PM ET
After-Market: $218.85 +0.02 (0.01%) 7:24 PM ET
3-Hold of 5 3
B Value A Growth D Momentum B VGM
Brokerage Recommendations
Current ABR | 1.41 |
ABR (Last week) | 1.41 |
# of Recs in ABR | 11 |
Average Target Price | $351.67 |
LT Growth Rate | 14.00% |
Industry | Medical Services |
Industry Rank by ABR | 156 of 253 |
Current Quarter EPS Est: | 2.70 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 9 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.41 | 1.41 | 1.41 | 1.25 | 1.05 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.